GS-9973: Interim Phase II data

Interim data from 78 evaluable patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL) in the single-arm, open-label,

Read the full 224 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE